Read More 2 minute read Funding News News CytoReason Secures $80 Million to Advance Computational Disease Models Key Highlights $80 million funding secured from OurCrowd, NVIDIA, Pfizer, and Thermo Fisher. Investment to expand AI disease… byChris-Anne RoqueJuly 24, 2024